296 related articles for article (PubMed ID: 27956623)
1. Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5.
Vogiatzi F; Brandt DT; Schneikert J; Fuchs J; Grikscheit K; Wanzel M; Pavlakis E; Charles JP; Timofeev O; Nist A; Mernberger M; Kantelhardt EJ; Siebolts U; Bartel F; Jacob R; Rath A; Moll R; Grosse R; Stiewe T
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):E8433-E8442. PubMed ID: 27956623
[TBL] [Abstract][Full Text] [Related]
2. Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis.
Pavlakis E; Neumann M; Merle N; Wieboldt R; Wanzel M; Ponath V; Pogge von Strandmann E; Elmshäuser S; Stiewe T
J Exp Clin Cancer Res; 2023 Aug; 42(1):203. PubMed ID: 37563605
[TBL] [Abstract][Full Text] [Related]
3. ENTPD5, an endoplasmic reticulum UDPase, alleviates ER stress induced by protein overloading in AKT-activated cancer cells.
Shen Z; Huang S; Fang M; Wang X
Cold Spring Harb Symp Quant Biol; 2011; 76():217-23. PubMed ID: 22169232
[TBL] [Abstract][Full Text] [Related]
4. The ER UDPase ENTPD5 promotes protein N-glycosylation, the Warburg effect, and proliferation in the PTEN pathway.
Fang M; Shen Z; Huang S; Zhao L; Chen S; Mak TW; Wang X
Cell; 2010 Nov; 143(5):711-24. PubMed ID: 21074248
[TBL] [Abstract][Full Text] [Related]
5. The UDPase ENTPD5 regulates ER stress-associated renal injury by mediating protein N-glycosylation.
Xu L; Zhou Y; Wang G; Bo L; Jin B; Dai L; Lu Q; Cai X; Hu L; Liu L; Wu Y; Chang X; Huang Y; Song L; Zhang T; Wang Y; Xiao Y; Zhang F; Liu L; Shi M; Wang T; Guo B
Cell Death Dis; 2023 Feb; 14(2):166. PubMed ID: 36849424
[TBL] [Abstract][Full Text] [Related]
6. p53 gain-of-function mutations promote metastasis via ENTPD5 upregulation and enhanced N-glycoprotein folding.
Timofeev O; Stiewe T
Mol Cell Oncol; 2017; 4(2):e1288678. PubMed ID: 28401189
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic Cancer Progression Relies upon Mutant p53-Induced Oncogenic Signaling Mediated by NOP14.
Du Y; Liu Z; You L; Hou P; Ren X; Jiao T; Zhao W; Li Z; Shu H; Liu C; Zhao Y
Cancer Res; 2017 May; 77(10):2661-2673. PubMed ID: 28280038
[TBL] [Abstract][Full Text] [Related]
8. Pro-metastatic p53 mutants control folding of N-glycoproteins.
Schneikert J; Stiewe T
Cell Cycle; 2017 Apr; 16(7):591-592. PubMed ID: 28166433
[No Abstract] [Full Text] [Related]
9. Resveratrol triggers ER stress-mediated apoptosis by disrupting N-linked glycosylation of proteins in ovarian cancer cells.
Gwak H; Kim S; Dhanasekaran DN; Song YS
Cancer Lett; 2016 Feb; 371(2):347-53. PubMed ID: 26704305
[TBL] [Abstract][Full Text] [Related]
10. BAG2 promotes tumorigenesis through enhancing mutant p53 protein levels and function.
Yue X; Zhao Y; Liu J; Zhang C; Yu H; Wang J; Zheng T; Liu L; Li J; Feng Z; Hu W
Elife; 2015 Aug; 4():. PubMed ID: 26271008
[TBL] [Abstract][Full Text] [Related]
11. Gain-of-function of mutant p53: mutant p53 enhances cancer progression by inhibiting KLF17 expression in invasive breast carcinoma cells.
Ali A; Shah AS; Ahmad A
Cancer Lett; 2014 Nov; 354(1):87-96. PubMed ID: 25111898
[TBL] [Abstract][Full Text] [Related]
12. Gain-of-function mutant p53 activates small GTPase Rac1 through SUMOylation to promote tumor progression.
Yue X; Zhang C; Zhao Y; Liu J; Lin AW; Tan VM; Drake JM; Liu L; Boateng MN; Li J; Feng Z; Hu W
Genes Dev; 2017 Aug; 31(16):1641-1654. PubMed ID: 28947497
[TBL] [Abstract][Full Text] [Related]
13. The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.
Wei S; Wang H; Lu C; Malmut S; Zhang J; Ren S; Yu G; Wang W; Tang DD; Yan C
J Biol Chem; 2014 Mar; 289(13):8947-59. PubMed ID: 24554706
[TBL] [Abstract][Full Text] [Related]
14. ENTPD5 induces apoptosis in lung cancer cells via regulating caspase 3 expression.
Xue Y; Wu L; Liu Y; Ma Y; Zhang L; Ma X; Yang Y; Chen J
PLoS One; 2015; 10(3):e0120046. PubMed ID: 25794010
[TBL] [Abstract][Full Text] [Related]
15. ENTPD5-mediated modulation of ATP results in altered metabolism and decreased survival in gliomablastoma multiforme.
Zadran S; Amighi A; Otiniano E; Wong K; Zadran H
Tumour Biol; 2012 Dec; 33(6):2411-21. PubMed ID: 22992974
[TBL] [Abstract][Full Text] [Related]
16. Pontin, a new mutant p53-binding protein, promotes gain-of-function of mutant p53.
Zhao Y; Zhang C; Yue X; Li X; Liu J; Yu H; Belyi VA; Yang Q; Feng Z; Hu W
Cell Death Differ; 2015 Nov; 22(11):1824-36. PubMed ID: 25857266
[TBL] [Abstract][Full Text] [Related]
17. Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.
Di Fiore R; Marcatti M; Drago-Ferrante R; D'Anneo A; Giuliano M; Carlisi D; De Blasio A; Querques F; Pastore L; Tesoriere G; Vento R
Bone; 2014 Mar; 60():198-212. PubMed ID: 24373920
[TBL] [Abstract][Full Text] [Related]
18. Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities.
Iyer SV; Parrales A; Begani P; Narkar A; Adhikari AS; Martinez LA; Iwakuma T
Oncotarget; 2016 Feb; 7(5):5401-15. PubMed ID: 26700961
[TBL] [Abstract][Full Text] [Related]
19. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S
Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072
[TBL] [Abstract][Full Text] [Related]
20. ONZIN Upregulation by Mutant p53 Contributes to Osteosarcoma Metastasis Through the CXCL5-MAPK Signaling Pathway.
Zhang Y; Hu Q; Li G; Li L; Liang S; Zhang Y; Liu J; Fan Z; Li L; Zhou B; Ruan Y; Yang X; Chen S; Mu T; Wang G; Xiong S
Cell Physiol Biochem; 2018; 48(3):1099-1111. PubMed ID: 30041188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
